Chemical formula: C₂₃H₁₆O₁₁ Molecular mass: 468.367 g/mol PubChem compound: 2882
Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A07EB01 | Cromoglicic acid | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EB Antiallergic agents, excl. corticosteroids |
| D11AH03 | Cromoglicic acid | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AH Agents for dermatitis, excluding corticosteroids |
| R01AC01 | Cromoglicic acid | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids |
| R03BC01 | Cromoglicic acid | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BC Antiallergic agents, excl. corticosteroids |
| S01GX01 | Cromoglicic acid | S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALLERGY RELIEF Eye drops, Solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| INTAL CFC-FREE Pressurised inhalation, suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NALCROM Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Cromoglicic acid is an active ingredient of these brands:
United States (US)
Austria (AT)
France (FR)
Germany (DE)
Hong Kong (HK)
Israel (IL)
Japan (JP)
Lithuania (LT)
Malta (MT)
Netherlands (NL)
New Zealand (NZ)
Nigeria (NG)
Poland (PL)
Singapore (SG)
South Africa (ZA)Spain (ES)
Tunisia (TN)
Turkey (TR)United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
